They plan to run similar trials on seven more patients over the next three years, backed by $4 million from the National ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

A trial has shown boosting diet with supplements could halt tumour growth in prostate cancer patients - opening the door to a ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

A new cancer treatment that uses light could remove the need for harsh chemotherapy or radiotherapy. Texas researchers have devised a way to use infrared light as a jackhammer that can tear cancer ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

French scientists work on a cancer vaccine, one of several in development that raises hopes of coming breakthroughs - Copyright AFP Abdul MAJEED French scientists ...